ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Pediatric Hemophilia: A Study of Prevalence and Risk Factors in Nineveh Province

Ahmad Talib Ibrahem,Khalid Satam Sultan,Asmaa Mohammed Khaleel.



Abstract
Download PDF Cited by 0 ArticlesPost

Hemophilia is a severe, hereditary clotting factor deficiency. Pediatric hemophilia treatment requires a multidisciplinary approach. Hemophilia should be evaluated in the newborn period if there is exceptional bleeding or a positive family history. The current study sought to determine the prevalence of hemophilia causes in children in Nineveh province. Patient information was gathered, and hemophilia factor testing was done at Ibn Sina Teaching Hospital. This study included 254 children aged less than a year to ten years. All patients were clinically assessed, and factor testing was carried out using the Staco kits. Blood samples were collected between March 2021 and March 2023. Blood type was also determined for all trial participants. Factor F-VIII had the greatest infection rate (203), followed by vWF (34) and F-IX (15). A total of 22 children with both F-VIII and vWF were included. Hemophilia factors (F-VIII, F-VII, and vWF) are most prevalent during ages

Key words: children, Factor, F-VIII, Hemophilia, vWF







Bibliomed Article Statistics

26
30
34
51
17
18
20
32
39
32
31
14
R
E
A
D
S

22

29

14

81

14

14

8

18

18

22

22

16
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.